Iwicki Mark T
SEC Form 4 insider trading activity
Iwicki Mark T has filed 2 SEC Form 4 filings (2 transaction rows) across 2 companies, including AKRO, KALA, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Dec 9, 2025.
On the most recent filing, Iwicki Mark T is listed as Director at KALA BIO, Inc. Inside the rolling window, Iwicki Mark T reported no open-market purchases and 1 open-market sale totaling $125K in KALA.
Companies traded
Other insiders at AKRO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$125K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Iwicki Mark T made?
Iwicki Mark T has filed 2 SEC Form 4 filings (2 transaction rows) across 2 companies, including AKRO, KALA since 2025.
Which companies does Iwicki Mark T trade?
Iwicki Mark T has filed SEC Form 4 disclosures for 2 companies, including AKRO, KALA.
When was Iwicki Mark T's most recent SEC Form 4 filing?
Iwicki Mark T's most recent SEC Form 4 filing on Tracefour is dated Dec 9, 2025.
What is Iwicki Mark T's total buy and sell value in the current window?
Inside the rolling retention window, Iwicki Mark T bought $0 and sold $125K based on SEC Form 4 filings.
What was Iwicki Mark T's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 154,894 KALA shares on 2025-10-23, worth $125K, per SEC Form 4 filings.